Business
Allyson J. Ocean, M.D., Joins Novocure Board of Directors
Dr. Ocean, a medical oncologist and Associate Professor of Clinical Medicine at Weill Cornell Medicine, brings decades of experience in oncology to Novocure
About this update from Novocure Limited
[{"type":"text","content":"\nDr. Ocean, a medical oncologist and Associate Professor of Clinical Medicine at Weill Cornell Medicine, brings decades of experience in oncology to Novocure\n\n ROOT, Switzerland--(BUSINESS WIRE)--\nNovocure (NASDAQ: NVCR) today announced that Allyson J. Ocean, M.D., has been elected to Novocure’s Board of Directors.\n\n“We are honored to welcome Dr. Ocean to our board of directors,” said William Doyle, Novocure’s Executive Chairman. “With her extensive expertise in gastrointestinal oncology and as a practicing clinician, Dr. Ocean will provide important insights and guidance as we strive to extend survival in some of the most aggressive forms of cancer through the development and commercialization of our innovative therapy.”\n\nDr. Ocean is an internationally recognized academic gastrointestinal medical oncologist specializing in translational and clinical research, development of novel therapeutics and patient advocacy. Dr. Ocean is an Associate Professor of Clinical Medicine at Weill Cornell Medicine, where she has worked since 2004.\n\nDr. Ocean is co-founder and Scientific Advisory Board Chair of Let’s Win Pancreatic Cancer, an award-winning non-profit organization missioned to increase access to treatment options and clinical trials for patients with pancreatic cancer. Let’s Win received the inaugural Biden Cancer Initiative FIERCE Award for Leadership through Exemplary and Awesome Purpose for its transformative impact on the lives of cancer patients. Additionally, Dr. Ocean serves on several scientific advisory boards. Dr. Ocean graduated cum laude from Tufts University and received her M.D. with AOA honors from the Tufts University School of Medicine. She is the author of numerous peer-reviewed articles and abstracts and is an active member of several professional societies, including the American Society of Clinical Oncology and American Association for Cancer Research.\n\n“I look forward to working with the esteemed individuals on Novocure’s board to advance our mission to help patients who currently have limited treatment options,” Dr. Ocean said. “As a clinician, I understand what these patients go through every day. The reality of cancer therapy is that many treatments are poorly tolerated and have harsh side effects even when they are effective. Through science, we can deliver better treatments to more patients.”...